Cite
Schlack K, Krabbe LM, Rahbar K, et al. ALP bouncing and LDH normalization in bone metastatic castration-resistant prostate cancer patients under therapy with Enzalutamide: an exploratory analysis. Transl Androl Urol. 2021;10(10):3986-3999doi: 10.21037/tau-20-1117.
Schlack, K., Krabbe, L. M., Rahbar, K., Isenberg, K., Semjonow, A., Schrader, A. J., & Boegemann, M. (2021). ALP bouncing and LDH normalization in bone metastatic castration-resistant prostate cancer patients under therapy with Enzalutamide: an exploratory analysis. Translational andrology and urology, 10(10), 3986-3999. https://doi.org/10.21037/tau-20-1117
Schlack, Katrin, et al. "ALP bouncing and LDH normalization in bone metastatic castration-resistant prostate cancer patients under therapy with Enzalutamide: an exploratory analysis." Translational andrology and urology vol. 10,10 (2021): 3986-3999. doi: https://doi.org/10.21037/tau-20-1117
Schlack K, Krabbe LM, Rahbar K, Isenberg K, Semjonow A, Schrader AJ, Boegemann M. ALP bouncing and LDH normalization in bone metastatic castration-resistant prostate cancer patients under therapy with Enzalutamide: an exploratory analysis. Transl Androl Urol. 2021 Oct;10(10):3986-3999. doi: 10.21037/tau-20-1117. PMID: 34804841; PMCID: PMC8575579.
Copy
Download .nbib